Previous studies have shown that HAS is the most common of the AFP-producing gastric cancers (GCs), and HAS is commonly believed to have more aggressive biobehaviour and poorer prognosis than cancers without HCC-like morphology [6]. The gene discussed is AFP; the disease is cancer.